Inmune Bio INMB
NASDAQ INMB
$1.10 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Inmune Bio (INMB) Treasury Stock (2017 - 2023)

Updated

Analysis

Inmune Bio (INMB) Treasury Stock (2017 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Stock (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -3.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 76.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.62 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 64.59 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.20 Bn
10 Inmune Bio 30.71 Mn -50.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 799,000.00
Sep 30, 2020 50,000.00
Jun 30, 2020 50,000.00
Mar 31, 2020 50,000.00
Dec 31, 2019 50,000.00
Sep 30, 2019 50,000.00
Jun 30, 2019 50,000.00
Mar 31, 2019 4.68 Mn
Dec 31, 2018 4.68 Mn
Dec 31, 2017 50,000.00
API Access

Inmune Bio Treasury Stock API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=INMB&period=max&api_key=YOUR_API_KEY